CRISPR/Cas9 technology generated a C to T change at position 769 (c.769C>T) resulting in an arginine to cysteine substitution at amino acid 257 (p.R257C). This is the most frequently occurring variant in patients with megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS). (J:344876)